Crownlink
Databases
Biospecimen Request
Our Services
Oncology & IO Solutions
Preclinical Services
Patient-Derived Translational Oncology
Biomarker & Bioanalysis Services
Clinical Biomarker & Biospecimen Services
Bioinformatics & Data Solutions
Therapeutic Modalities
ADCs
Cell & Gene Therapy
Radiopharmaceuticals
Cancer Indications
AML / Liquid Tumors
Breast Cancer
Drug Targets
KRAS
EGFR
IO Targets
PARP
Drug Resistance
Drug Combinations
Drug Discovery
Target Discovery & Validation
Drug Screening
Efficacy
Pharmacology
In Silico Solutions
Consulting
In Vitro Services
Cell Lines & Panels
OmniScreen
Patient-derived Organoids
Organoid Xplore
Drug Screening & Combination Analysis
Complex IO Assays
High Content Imaging
DMPK / Tox
In Vivo DMPKT
Bioanalysis
Engineered Models & Services
Target KO & CRISPR
In Vivo Services
PDX Models
CDX Models
Syngeneic Models
Humanized GEMMs
Tumor Homografts
Humanized Models
(HSC & PBMC)
Orthotopic / Metastatic &
Imaging-enabled Models
Imaging Technology
Digital Pathology
High Content Imaging
Patient Derived Systems
PDX Mouse Clinical Trials
Organoid and Matched PDX
Ex Vivo Patient Tissue
3D Bone Marrow Models
Biomarker Discovery Services
OmniScreen
Organoid Xplore
PDX Mouse Clinical Trials
Spatial Biology &
Tissue-based Biomarker Analysis
Histology & Immunostaining
(H&E, IHC, IF, mIF)
NanoString GeoMx
10x Genomics Visium
Tumor Tissue Microarrays
Digital Pathology
Protein Analysis
Immunoassays
(ELISA, MSD, Luminex)
Flow Cytometry
Mass Spec-proteomics
Discovery Proteomics
PTM Proteomics & Phosphoproteomics
Rare Cell Analysis
DNA / RNA Analysis
Standard Genomics
Next Generation Sequencing
Single Cell Sequencing
NanoString nCounter
Optical Genome Mapping
Mouse I/O RNA-seq Panel
Microbiome Sequencing
NanoString GeoMx
10x Genomics Visium
Cell Line Authentication
Model-derived Biobank
Tumor Tissue Microarrays
Immune Monitoring
Bioanalysis
Biofluid Testing
Regulatory Accreditations
Specialty Biomarker Services
Longitudinal Plasma
Clinical Biomarkers
Human Biospecimens
Preclinical Cancer Model Databases
Drug Combinations
Bioinformatics Consulting
Preclinical Biomarker Discovery
Omics Data Analysis
Oncology & IO Solutions
Therapeutic Modalities
ADCs
Cell & Gene Therapy
Radiopharmaceuticals
Cancer Indications
AML / Liquid Tumors
Breast Cancer
Drug Targets
KRAS
EGFR
IO Targets
PARP
Drug Resistance
Drug Combinations
Drug Discovery
Target Discovery & Validation
Drug Screening
Efficacy
Pharmacology
In Silico Solutions
Consulting
Preclinical Services
In Vitro Services
Cell Lines & Panels
OmniScreen
Patient-derived Organoids
Organoid Xplore
Drug Screening & Combination Analysis
Complex IO Assays
High Content Imaging
DMPK / Tox
In Vivo DMPKT
Bioanalysis
Engineered Models & Services
Target KO & CRISPR
In Vivo Services
PDX Models
CDX Models
Syngeneic Models
Humanized GEMMs
Tumor Homografts
Humanized Models
(HSC & PBMC)
Orthotopic / Metastatic &
Imaging-enabled Models
Imaging Technology
Digital Pathology
High Content Imaging
Patient-Derived Translational Oncology
Patient Derived Systems
PDX Mouse Clinical Trials
Organoid and Matched PDX
Ex Vivo Patient Tissue
3D Bone Marrow Models
Biomarker Discovery Services
OmniScreen
Organoid Xplore
PDX Mouse Clinical Trials
Biomarker & Bioanalysis Services
Spatial Biology &
Tissue-based Biomarker Analysis
Histology & Immunostaining
(H&E, IHC, IF, mIF)
NanoString GeoMx
10x Genomics Visium
Tumor Tissue Microarrays
Digital Pathology
Protein Analysis
Immunoassays
(ELISA, MSD, Luminex)
Flow Cytometry
Mass Spec-proteomics
Discovery Proteomics
PTM Proteomics & Phosphoproteomics
Rare Cell Analysis
DNA / RNA Analysis
Standard Genomics
Next Generation Sequencing
Single Cell Sequencing
NanoString nCounter
Optical Genome Mapping
Mouse I/O RNA-seq Panel
Microbiome Sequencing
NanoString GeoMx
10x Genomics Visium
Cell Line Authentication
Model-derived Biobank
Tumor Tissue Microarrays
Immune Monitoring
Bioanalysis
Biofluid Testing
Clinical Biomarker & Biospecimen Services
Regulatory Accreditations
Specialty Biomarker Services
Longitudinal Plasma
Clinical Biomarkers
Human Biospecimens
Bioinformatics & Data Solutions
Preclinical Cancer Model Databases
Drug Combinations
Bioinformatics Consulting
Preclinical Biomarker Discovery
Omics Data Analysis
Publications & Resources
Blog
Podcast
Publications
Resources
Blog
Podcast
Publications
Resources
About Us
Company
Leadership & SAB
News & Events
Careers
Awards & Testimonials
Company
Leadership & SAB
News & Events
Careers
Awards & Testimonials
Crownlink
Databases
Biospecimen Request
Contact Us
Contact Us
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Benjamin Wilkin
Select Topic
Preclinical Modeling
Immuno-Oncology
Orthotopic Models
Biomarkers & Diagnostics
Genomics & Sequencing Techniques
Oncogenic Pathways
Targeted Therapeutics
Clinical Trials
Podcast
Hematologic Malignancies
Nov 26, 2025
Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates
Learn More
Sep 1, 2025
The Role of Biomarkers in AML Drug Discovery
Learn More
Aug 25, 2025
The Future of Antibody-Drug Conjugates: Advances in Bioconjugation, Linkers, and Payload Optimization
Learn More
Aug 7, 2025
Harnessing Mass Spectrometry for Biomarker Discovery in AML Drug Development
Learn More
Jul 28, 2025
Targeted Therapeutics
Off-target toxicity in antibody-drug conjugates
Learn More
Jul 3, 2025
Preclinical Modeling
The role of patient-derived xenograft models (PDX) in antibody-drug conjugate development
Learn More
Jul 1, 2025
Targeted Therapeutics
Key assays and analytical techniques for the development of antibody drug conjugates
Learn More
Jan 2, 2025
ADCs
|
Targeted Therapeutics
The Role of Organoids in Antibody-Drug Conjugate Development
Learn More
Dec 18, 2024
Targeted Therapeutics
World ADC San Diego 2024: A recap of the latest breakthroughs and innovations in ADC development
Learn More
1